Is There a LOMU Defense Receptor in Banked T Cells?

The ADR strategy was developed in Max Lamonkensler by a very talented graduate student, Bayon Mo and the preclinical data has been published. We're not yet at the level to really directly compete with autologous products that are FDA approved but we certainly want to be there. There's enough science going on with a lot of the possibilities that have been covered in the series that I honestly think we can get there. But we've work to do when everybody interested in hematology research should be encouraged to want to get there.